NASDAQ$OPRX

OptimizeRx Corporation · Q2 2016 earnings

Q2 2016 earnings · · Investor relations

Headline financials

Total Revenue

$1.91M

Previous: $1.71M+12.2%
EPS (adj)

-$0.03

Previous: -$0.01-200.0%
Capital Expenditures

-$19.8K

No prior period
Free Cash Flow

-$612K

No prior period
Net Income

-$592K

Previous: -$157K-276.5%
Operating Income

-$603K

Previous: -$158K-282.5%
Gross Profit

$990K

Previous: $823K+20.3%
Cash & Equivalents

$7.57M

Previous: $3.65M+107.5%
Total Assets

$11M

Previous: $6.98M+57.5%
Stock-Based Comp

$76.2K

Previous: $56.2K+35.7%

Revenue & EPS history

OptimizeRx · Revenue · Quarterly

$1.91M

Q2 2016+12.2%vs Q2 2015
Beat estimate in 1 of 2 quarters(50%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2016

Historical avgQ2 2016

+1.3%

Avg return

Earnings day

+4.5%

Avg return

5 days after

+5.6%

Avg return

30 days after

55%

30 / 55 earnings

Positive

+51.7%

Q4 2024

Best reaction

-34.5%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-22.6%-19.7%-17.5%
Q4 2025-10.5%-11.4%-12.9%
Q3 2025-17.0%-14.7%-24.8%
Q1 2025+20.7%+24.2%+63.6%
Q4 2024+51.7%+99.8%+96.4%
Q3 2024-30.5%-28.1%-14.6%
Q2 2024+1.2%+4.5%-8.9%
Q1 2024+25.0%+20.4%+5.5%
Q4 2023+13.6%+4.9%+20.1%
Q3 2023+13.9%+7.4%+14.1%
Q2 2023-29.3%-32.6%-38.9%
Q1 2023-6.2%-9.1%+2.6%
Q4 2022-14.2%-25.0%-14.5%
Q3 2022+22.2%+51.4%+28.6%
Q2 2022-34.5%-31.6%-33.4%
Q1 2022-2.9%-17.9%-9.9%
Q4 2021+14.0%+2.4%-5.5%
Q3 2021-8.1%-6.6%-36.8%
Q2 2021+20.9%+16.0%+27.7%
Q1 2021+4.4%-11.1%+2.1%
Q4 2020+0.8%-0.2%-17.4%
Q3 2020+6.9%+13.5%+32.6%
Q2 2020+11.0%+10.2%+21.8%
Q1 2020+11.5%+16.0%+33.6%
Q4 2019-26.0%+3.6%-36.8%
Q3 2019-17.6%-19.5%-30.1%
Q2 2019+2.6%+0.8%+13.9%
Q1 2019+18.5%+22.8%+17.7%
Q4 2018+1.1%-0.2%+22.6%
Q3 2018-4.6%-0.7%-5.7%
Q2 2018+15.9%+23.4%+26.7%
Q1 2018+0.0%+7.1%+32.5%
Q4 2017+0.0%+10.7%+14.5%
Q3 2017+15.4%+25.6%+33.3%
Q2 2017+16.4%+9.1%+15.5%
Q1 2017+10.3%+20.6%+17.6%
Q4 2016-10.6%+7.9%+1.3%
Q3 2016-13.3%+0.0%-14.3%
Q2 2016+0.9%+0.0%-3.5%
Q4 2015+3.2%
Q2 2015-3.2%
Q4 2014+2.3%
Q3 2014-4.3%
Q2 2014+8.3%
Q4 2012+11.2%
Q2 2012+5.4%
Q1 2012-10.4%
Q4 2011+0.0%
Q3 2011-1.9%
Q2 2011+20.0%
Q1 2011-15.2%
Q4 2010+0.0%
Q3 2010+15.0%
Q2 2010-10.7%
Q1 2010+1.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro